Search for: "Novartis AG"
Results 41 - 60
of 440
Sorted by Relevance
|
Sort by Date
25 Apr 2007, 8:14 pm
By Jason Derry -- Cytos Biotechnology AG has granted a worldwide, exclusive license to Novartis to develop, manufacture, and commercialize its therapeutic vaccine for nicotine addiction, CYT002-NicQb. [read post]
19 May 2010, 8:23 am
A federal jury on Monday found that the U.S. unit of Swiss drug maker Novartis AG engaged in a "pattern or practice" of discrimination against its female employees. [read post]
Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021
1 Jun 2021, 2:55 pm
Novartis launched the Merlin trial to see if the more frequent dosing could help age-related macular degeneration patients who still have unresolved retinal fluid despite anti-VEGF therapy. [read post]
11 Dec 2018, 9:46 pm
The first, Novartis AG v. [read post]
15 Feb 2015, 9:43 pm
Novartis AG et al. v. [read post]
30 Sep 2010, 5:56 am
Counsel, Sept. 2010 at 28, offers a stunning metric about the number of invoices Novartis AG’s legal and intellectual property groups cope with annually. [read post]
22 Apr 2007, 9:51 pm
By Donald Zuhn -- Last Thursday, Novartis AG announced that it had signed an exclusive license with Antisoma PLC for the worldwide rights to the cancer therapeutic AS1404. [read post]
16 Jan 2014, 7:31 pm
Procedural HistoryNovartis AG, Novartis Vaccines and Diagnostics, Inc., and Novartis Corporation (collectively, Novartis) filed suits that challenged the determinations by the Patent and Trademark Office of how much time to add, under 35 U.S.C. [read post]
26 Jan 2012, 9:32 am
According to recent employee misclassification news that our Anaheim, California labor and employment lawyers have been following, a unit of Novartis AG, the Swiss pharmaceutical company, received preliminary approval from a New York U.S. [read post]
26 Jun 2014, 7:44 am
Recently, the United States Patent and Trademark Office proposed changes to the rules of practice pertaining to the patent term adjustment provisions in view of the decision by the United States Court of Appeals for the Federal Circuit in Novartis AG v. [read post]
19 Nov 2012, 11:00 pm
In another significant Patent Term Adjustment (PTA) case decided last week (Novartis AG v. [read post]
2 Aug 2007, 12:44 pm
The drug company Novartis AG will have to defend itself against sex-discrimination claims brought by a group of female sales employees in a $100 million class-action lawsuit, a federal judge has ruled. [read post]
17 Nov 2020, 12:30 pm
The American Society of Retina Specialists Research and Safety in Therapeutics (ReST) committee began to receive reports of intraocular inflammation alone and retinal vasculitis in patients who underwent injections of Beovu (brolucizumab, Novartis) following its FDA approval for neovascular age-related macular degeneration in October 2019. [read post]
7 Apr 2013, 9:37 pm
Noven Pharmaceuticals Inc. et al. 1:13-cv-00527; filed April 3, 2013 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
3 Feb 2014, 9:51 pm
Noven Pharmaceuticals Inc. et al. 1:14-cv-00111; filed January 30, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; Novartis International Pharmaceutical, LTD; LTS Lohmann Therapie-Systeme AG • Defendants: Noven Pharmaceuticals Inc.; Noven Therapeutics LLC; Hisamitsu Pharmaceutical Co. [read post]
1 Dec 2013, 8:49 pm
Roxane Laboratories, Inc. 2:13-cv-07184; filed November 27, 2013 in the District Court of New Jersey • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis Pharma AG; Aventisub II Inc. [read post]
19 Aug 2010, 9:02 pm
Depending on the product in question, competition concerns arose in either a few or a larger number of EC member states.The FTC complaint and proposed consent order, In the Matter of Novartis AG, FTC Dkt. [read post]
23 Feb 2022, 12:45 pm
"Revised: 6/2020" (Posted by Tom Lamb at Drug Injury Watch) Beovu (brolucizumab) was approved by the FDA in 2019 as a treatment for neovascular (wet) age-related macular degeneration (AMD). [read post]
29 Jun 2014, 9:21 pm
Mylan Inc. et al. 1:14-cv-00777; filed June 19, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
30 Mar 2007, 5:36 pm
Article in the Wall Street Journal -- Novartis to Suspend U.S. [read post]
